SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLAS CEO Angelos Stergious comments about approaching REGAL clinical catalysts and allowing unblinded data to speak for itself, alongside healthcare-industry endorsements of GPS as a potential AML treatment breakthrough. Traders remain divided between optimism that the Phase 3 trial is nearing its final 80-event trigger and concerns about trial design, with the companys last officially confirmed count still at 78 events.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops preliminary Q2 update and convertible-note exchange amendment are driving attention, with traders focusing on improved operating profitability and capped share dilution through a larger cash settlement. Bulls view the changes as supportive of buybacks and potential short covering, while skeptics point to weaker sales, remaining debt and unusual warrant activity as reasons for caution; the warrant move has also fueled unconfirmed squeeze speculation.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Escalating U.S.-Iran tensions and uncertainty around Strait of Hormuz shipping are driving attention to CCL through their impact on oil prices, fuel costs, and travel demand. Traders are split between bearish concerns over geopolitical risk, debt, and persistent selling, and bullish views that strong bookings, deleveraging, dividends, and buybacks leave the shares undervalued.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is drawing attention ahead of its upcoming earnings release, with traders positioning for a potentially sharp reaction and debating whether strong AI-driven cybersecurity demand and recent sector strength justify its elevated valuation. Bullish participants expect a beat and raised guidance, while others are buying puts or anticipating a post-earnings selloff.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention after an institutional financing that supports the ROBBIN Phase 3 trial of BOT/BAL in MSS colorectal cancer, alongside encouraging neoadjuvant NEST data and the shift away from BATTMAN. Traders view the funding and investor involvement as a potential turnaround, while skeptics focus on warrant-related dilution, management concerns, and the long timeline to meaningful Phase 3 results.

Corvex, Inc. is an AI cloud computing company, which specializes in GPU-accelerated infrastructure for AI workloads. Its products include GPU Clusters, Confidential Computing, Inference as a Service and GPU Node. The firm offers solutions include AI model builders, enterprises, federal and sovereign solutions. The company was founded by Seth Mitchell Demsey, Jay Crystal on October 21, 2024 and is headquartered in Arlington, VA.

Corvex Inc.

Movano Inc

Corvexs multi-year agreement to provide NVIDIA Blackwell GPU clusters to an AI infrastructure customer, alongside expanded data-center capacity, is driving attention as MOVE pivots toward AI infrastructure. Traders are broadly bullish on the NVIDIA association and perceived low float, framing the setup as a potential short squeeze, while others cite dilution risk, valuation, execution, and the limited disclosed revenue as reasons for caution.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernovas quarterly results triggered the focus: an earnings miss and concerns about wind-segment execution and tariffs drove a sharp selloff despite stronger revenue, raised guidance, and a record backlog tied to power-grid and AI data-center demand. Traders are divided between dip buyers who view the reaction as temporary and bears citing elevated valuation, repeated volatility, and execution risks.

Endeavour Silver Corp. is a mineral company, which engages in the evaluation, acquisition, development and exploitation of precious metal properties in Mexico and Chile. The firm's projects include the Terronera property in Jalisco, the El Compas property, the Guanacevi Mine in Durango, Bolanitos Mines in Guanajuato, and the Parral project in Chihuahua, Mexico. The company was founded by Bradford James Cooke on March 11, 1981 and is headquartered in Vancouver, Canada.

Endeavour Silver Corp.

Rising silver prices and expectations for production growth at Endeavours Terronera mine are driving interest, with traders viewing the company as a high-beta way to play the precious-metals market. Debate centers on EXKs underperformance versus silver and peer miners, alongside concerns about the Terronera blockade, hedging decisions, costs, and management execution.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Hawkish Federal Reserve messaging from Kevin Warsh has lifted expectations for a potential rate hike, while rising Treasury yields and persistent inflation concerns weigh on the Dow ETF. Traders debate whether the macro pressure will trigger a broader correction, although some view any pullback as a buying opportunity; oil-related geopolitical risks add to the uncertainty.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Activist investor pressure and potential divestitures are in focus following Toms Capital's top-five stake build. Community debate centers on whether Coterra merger synergies and elevated oil prices will finally spark a re-rating, amid frustration over chronic underperformance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Did KPRX Stock Surge 17% Pre-Market Today?

Equity

The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting...

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know

Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Reported GAAP EPS of -$0.34 up 37.04% YoY

Kiora Pharmaceuticals continues to incur net losses while facing clinical trial execution risks and dependence on the successful completion of strategic transactions to secure additional capital for future operational needs.

Kiora Pharmaceuticals strengthened its financial position with a $24.0 million private placement, extending its operating runway into late 2028 while advancing clinical trials for KIO-301 with fully reimbursed development costs.

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Kiora Pharmaceuticals Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.62
Prev Close	$2.66
Open	$2.67
Dividend Yield	0.00%
50-Day Moving Average	$2.57
Beta	0.70
Avg. Volume	19,927.69
PE Ratio	-0.99

52-Week High	$2.95
52-Week Low	$1.76
Market Capitalization	$11.59M
EPS (Annual)	-$2.60
Price to Book	0.69
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info